Overexpression of Reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 7, 2013, Pages 1358-1366

  Ren, Juchao ^a,b   Li, Wenjuan ^c   Liu, Hainan ^a   Yan, Lei ^a   Jiao, Wei ^a   Li, Dawei ^a   Tang, Yueqing ^a   Gu, Gangli ^a   Xu, Zhonghua ^a  

^a SHANDONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Invasion; Prognosis; RCC; Reptin; Senescence

Indexed keywords

BETA GALACTOSIDASE; CELL PROTEIN; MATRIGEL; MULTIPROTEIN COMPLEX; REPTIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL MIGRATION; CLONOGENESIS; CONTROLLED STUDY; CYTOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SENESCENCE; STAINING; TUMOR INVASION;

INVASION; PROGNOSIS; RCC; REPTIN; SENESCENCE;

CARCINOMA, RENAL CELL; CARRIER PROTEINS; CELL AGING; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA HELICASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84884673814     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.01.004     Document Type: Article

References (27)

1. Huber O., Menard L., Haurie V., et al. Pontin and reptin, two related ATPases with multiple roles in cancer. Cancer Res 2008, 68:6873-6876.
2. Baek S.H. When ATPases pontin and reptin met telomerase. Dev Cell 2008, 14:459-461.
3. Gallant P. Control of transcription by pontin and reptin. Trends Cell Biol 2007, 17:187-192.
4. Li W., Zeng J., Li Q., et al. Reptin is required for the transcription of telomerase reverse transcriptase and overexpressed in gastric cancer. Mol Cancer 2010, 9:132.
5. Venteicher A.S., Meng Z., Mason P.J., et al. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 2008, 132:945-957.
6. Blanc J.F., Lalanne C., Plomion C., et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005, 5:3778-3789.
7. Ki D.H., Jeung H.C., Park C.H., et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 2007, 121:2005-2012.
8. Dehan E., Ben-Dor A., Liao W., et al. Chromosomal aberrations and gene expression profiles in non-small-cell lung cancer. Lung Cancer 2007, 56:175-184.
9. John N., Eble G.S., Jonathan I., et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004, World Health Organization Classification of Tumours, IARC Press, Lyon.
10. Fuhrman S.A., Lasky L.C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6:655-663.
11. Li W., Li L., Liu Z., et al. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues. Cancer Lett 2008, 260:28-36.
12. Li W., Ge Z., Liu C., et al. CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res 2008, 14:3722-3728.
13. Dimri G.P., Lee X., Basile G., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995, 92:9363-9367.
14. Ikura T., Ogryzko V.V., Grigoriev M., et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000, 102:463-473.
15. Kim J.H., Kim B., Cai L., et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 2005, 434:921-926.
16. Bauer A., Chauvet S., Huber O., et al. Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signaling activity. EMBO J 2000, 19:6121-6130.
17. Bauer A., Huber O., Kemler R. Pontin52, an interaction partner of β-catenin, binds to the TATA box binding protein. Proc Natl Acad Sci U S A 1998, 95:14787-14792.
18. Wood M.A., McMahon S.B., Cole M.D. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 2000, 5:321-330.
19. Izumi N., Yamashita A., Iwamatsu A., et al. AAA+ proteins RUVBL1 and RUVBL2 coordinate PIKK activity and function in nonsense-mediated mRNA decay. Sci Signal 2010, 3. ra27.
20. Sigala B., Edwards M., Puri T., et al. Relocalization of human chromatin remodeling cofactor TIP48 in mitosis. Exp Cell Res 2005, 310:357-369.
21. Rousseau B., Menard L., Haurie V., et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 2007, 46:1108-1118.
22. Xie X., Chen Y., Xue P., et al. RUVBL2, a novel AS160-binding protein, regulates insulin-stimulated GLUT4 translocation. Cell Res 2009, 19:1090-1097.
23. Nardella C., Clohessy J.G., Alimonti A., et al. Pro-senescence therapy for cancer treatment. Nat Rev Cancer 2011, 11:503-511.
24. Menard L., Taras D., Grigoletto A., et al. In vivo silencing of reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence. J Hepatol 2010, 52:681-689.
25. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
26. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9:265-273.
27. Thiery J.P., Acloque H., Huang R.Y., et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.